“arteriovenous-malformation”的搜索结果，显示 511-520 项，共有 5676 项

1. 内分泌科- 临床试验- 妙佑医疗国际

   ... abnormalities (blood-based CHIP panel) in studying the predisposing risk factors for developing hematological toxicity including t-MN in PRRT-treated ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... abnormalities (blood-based CHIP panel) in studying the predisposing risk factors for developing hematological toxicity including t-MN in PRRT-treated ...

3. 房室管缺损- 诊断与治疗- 妙佑医疗国际

   Merck Manual Professional Version. https://www.merckmanuals.com/professional/pediatrics/congenital-cardiovascular-anomalies/atrioventricular-septal-defect.

4. 外科 - 临床试验- 妙佑医疗国际

   This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery.

5. 血管中心- 医生 - 妙佑医疗国际

   妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都有院区。医务人员掌握几十种专业技能，齐心协力，确保高品质治疗与 ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... malformation type I and syringomyelia. Breast Cancer, Reasoning, and Activity Intervention. Scottsdale/Phoenix, Ariz. The purpose of this study is to test ...

7. 内分泌科- 临床试验- 妙佑医疗国际

   ... abnormalities (blood-based CHIP panel) in studying the predisposing risk factors for developing hematological toxicity including t-MN in PRRT-treated ...

8. 神经科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to create a registry of patients having a clinical diagnosis and collect demographics, cognitive testing, blood ...

9. 神经科- 临床试验- 妙佑医疗国际

   Aims, purpose, or objectives: To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the ...

10. 法洛四联症- 医生与科室- 妙佑医疗国际

    ... venous return, Partial anomalous pulmonary venous return, Congenital mitral valve anomaly. 显示更多擅长领域 针对David S. Majdalany, M.D. ...